Sitka Biopharma
Dr. James McKiernan practices urology at New York-Presbyterian Hospital, specializing in urologic oncology, and has conducted multiple early-phase human trials of intravesical taxanes for bladder cancer.
This person is not in the org chart
This person is not in any offices
Sitka Biopharma
Sitka has developed a novel polymer platform technology that improves drug absorption for cancer treatments.